Screening for Cervical Cancer and Human Papillomavirus Vaccination in Israel: Recommendations

Jacob Bornstein, William A. Fisher, Gary M. Ginsberg, Oren Shavit, Eduardo Schejter, Mireia Diaz, F. Xavier Bosch

Research output: Contribution to journalComment/debate

3 Scopus citations
Original languageEnglish
Pages (from-to)158-160
Number of pages3
JournalVaccine
Volume31
Issue numberSUPPL.8
DOIs
StatePublished - 22 Nov 2013

Bibliographical note

Funding Information:
The work of F. Xavier Bosch and Mireia Diaz, was partially supported by public grants from the European Commission (7th Framework Programme grant HEALTH-F3-2010-242061, PREHDICT), from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI10/02995, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca – Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126) who had no role in data collection, analysis or interpretation of results.

Funding Information:
WAF: Has received consultant, travel, and research funding from Merck Canada.

Funding

The work of F. Xavier Bosch and Mireia Diaz, was partially supported by public grants from the European Commission (7th Framework Programme grant HEALTH-F3-2010-242061, PREHDICT), from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI10/02995, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca – Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126) who had no role in data collection, analysis or interpretation of results. WAF: Has received consultant, travel, and research funding from Merck Canada.

FundersFunder number
CIBERESP
Catalonian Government
Seventh Framework ProgrammeHEALTH-F3-2010-242061
European Commission
Generalitat de Catalunya
Agència de Gestió d'Ajuts Universitaris i de Recerca2009SGR126, 2005SGR00695
Instituto de Salud Carlos IIIFIS PI10/02995, RCESP C03/09, RD12/0036/0056, RTIC RD06/0020/0095, RTICESP C03/10
Merck Canada

    Cite this